This week at the UPC: Oct. 23-29
By Giorgi Dvalishvili ( October 29, 2026, 16:34 GMT | Insight) -- This week the Unified Patent Court ordered SK Nexilis to pay €1.1 million in costs, including those of an undecided conditional revocation counterclaim. Preliminary injunctions targeted Dreame’s Mira Mop and Pendulum’s probiotics, with the latter extending to Switzerland. Judges also rejected an objection to its authority to prevent patent withdrawal from frustrating validity proceedings.The question of who pays for an undecided patent challenge divided UPC local divisions: Mannheim allocated the costs to SK Nexilis, disagreeing with Munich’s earlier approach. In Milan, judges allowed Sandoz to pursue an order preventing Novo Nordisk from withdrawing approval of its semaglutide patent text, while finding insufficient evidence of misconduct by Novo Nordisk....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.